Scientific Reports (Feb 2022)

3D pCASL-perfusion in preoperative assessment of brain gliomas in large cohort of patients

  • A. I. Batalov,
  • N. E. Zakharova,
  • I. N. Pronin,
  • A. Yu. Belyaev,
  • E. L. Pogosbekyan,
  • S. A. Goryaynov,
  • A. E. Bykanov,
  • A. N. Tyurina,
  • A. M. Shevchenko,
  • K. D. Solozhentseva,
  • P. V. Nikitin,
  • A. A. Potapov

DOI
https://doi.org/10.1038/s41598-022-05992-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 7

Abstract

Read online

Abstract The aim of the study was to evaluate the role of pseudocontinuous arterial spin labeling perfusion (pCASL-perfusion) in preoperative assessment of cerebral glioma grades. The study group consisted of 253 patients, aged 7–78 years with supratentorial gliomas (65 low-grade gliomas (LGG), 188 high-grade gliomas (HGG)). We used 3D pCASL-perfusion for each patient in order to calculate the tumor blood flow (TBF). We obtained maximal tumor blood flow (maxTBF) in small regions of interest (30 ± 10 mm2) and then normalized absolute maximum tumor blood flow (nTBF) to that of the contralateral normal-appearing white matter of the centrum semiovale. MaxTBF and nTBF values significantly differed between HGG and LGG groups (p < 0.001), as well as between patient groups separated by the grades (grade II vs. grade III) (p < 0.001). Moreover, we performed ROC-analysis which demonstrated high sensitivity and specificity in differentiating between HGG and LGG. We found significant differences for maxTBF and nTBF between grade III and IV gliomas, however, ROC-analysis showed low sensitivity and specificity. We did not observe a significant difference in TBF for astrocytomas and oligodendrogliomas. Our study demonstrates that 3D pCASL-perfusion as an effective diagnostic tool for preoperative differentiation of glioma grades.